Komori
Share Issuance and Disposal4596Kubota Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice Regarding the Finalization of the Terms of Stock Options (Share Acquisition Rights)

For the 39th and 40th Stock Acquisition Rights approved on 18 March 2026, the previously undetermined exercise price, eligible allottees and number of rights have been finalized. The 39th Stock Acquisition Rights will be allocated to 3 Outside Directors and 1 employee, and the 40th Stock Acquisition Rights will be allocated to 1 external consultant of a subsidiary.

Worth reading
36Immaterial
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2850
units
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of Stock Options (Stock Acquisition Rights)

Intended allottee
Category Directors of the Company who are Audit and Supervisory Committee Members (all are Outside Directors) / Number of Employees 3 / Number of stock acquisition rights 750 rights, Category Employees of the Company / Number of Employees 1 / Number of stock acquisition rights 1,000 rights, Category External consultant of Kubota Vision, Inc. / Number of Employees 1 / Number of stock acquisition rights 1,100 rights
Terms of the stock acquisition rights
Exercise price
¥19,100 per stock acquisition right for both the 39th and 40th Stock Acquisition Rights (¥191 per share). Amendment provisions: Not disclosed
Number of Stock Acquisition Rights
39th Stock Acquisition Rights: 1,750 rights in total; 40th Stock Acquisition Rights: 1,100 rights in total. Unexercised balance: Not disclosed
Categories and Number of Persons Covered
Category Directors of the Company who are Audit and Supervisory Committee Members (all are Outside Directors) / Number of Employees 3 / Number allocated 750 rights, Category Employees of the Company / Number of Employees 1 / Number allocated 1,000 rights, Category External consultant of Kubota Vision, Inc. / Number of Employees 1 / Number allocated 1,100 rights
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of Stock Options (Stock Acquisition Rights)
Intended allotteeCategory Directors of the Company who are Audit and Supervisory Committee Members (all are Outside Directors) / Number of Employees 3 / Number of stock acquisition rights 750 rights, Category Employees of the Company / Number of Employees 1 / Number of stock acquisition rights 1,000 rights, Category External consultant of Kubota Vision, Inc. / Number of Employees 1 / Number of stock acquisition rights 1,100 rights
Exercise price¥19,100 per stock acquisition right for both the 39th and 40th Stock Acquisition Rights (¥191 per share). Amendment provisions: Not disclosed
Number of Stock Acquisition Rights39th Stock Acquisition Rights: 1,750 rights in total; 40th Stock Acquisition Rights: 1,100 rights in total. Unexercised balance: Not disclosed
Categories and Number of Persons CoveredCategory Directors of the Company who are Audit and Supervisory Committee Members (all are Outside Directors) / Number of Employees 3 / Number allocated 750 rights, Category Employees of the Company / Number of Employees 1 / Number allocated 1,000 rights, Category External consultant of Kubota Vision, Inc. / Number of Employees 1 / Number allocated 1,100 rights
Items this document does not state (23)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Previously undetermined matters relating to the stock options approved at the Board of Directors meeting held on 18 March 2026 have been finalized.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Finalization of the Terms of Stock Options (Share Acquisition Rights) | Kubota Pharmaceutical Holdings Co.,Ltd. (4596) timely disclosure | Komori